Terminal complement inhibition dampens the inflammation during COVID-19

Br J Haematol. 2020 Aug;190(3):e141-e143. doi: 10.1111/bjh.16916. Epub 2020 Jun 28.

Austin G Kulasekararaj^{1

2

3}, Ioanna Lazana¹, Joanna Large¹, Kristina Posadas², Helen Eagleton⁴, John Lord Villajin², Mark Zuckerman⁵, Shreyans Gandhi^{1

2}, Judith C W Marsh^{1

3}

¹ Department of Haematological Medicine, King's College Hospital-NHS Foundation Trust, London, UK.
² NIHR/Wellcome King's Clinical Research Facility, London, UK.
³ King's College London, London, UK.
⁴ Department of Haematology, Stoke Mandeville Hospital, Buckinghamshire, UK.
⁵ South London Specialist Virology Centre, King's College Hospital NHS Foundation Trust, London, UK.

No abstract available

Keywords: C5 inhibition; COVID-19; complement activation; paroxysmal nocturnal haemoglobinuria.

MeSH terms